Numinus Wellness Announces Clinical Marketing and Exclusive Data Partnership to Expand Access to Mental Health Care.
The landmark agreement includes the sale of US health clinics and a partnership to launch a technology-driven clinical management solution for mental health care providers.
Completed a definitive agreement with Stella for the sale of Numinus Wellness clinics for 3.53 million dollars
Focusing on business units and product development (“Numinus Network”) drives clinical efficiency and care reimbursement for mental health practitioners.
Stella will partner with Numinus to share performance data from a network of 12 mental health clinics, to support the development of advanced clinical management solutions for applications of mental health, including insurance reimbursement support.
It creates a light asset business that combines medical support, physician training and medical research with a strong balance sheet.
VANCOUVER, BC, November 15, 2024 /CNW/ – Numinus Wellness Inc. (“God“or”Company“) (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental health company that develops traditional and innovative behavioral therapies that include safe, evidence-based treatments assisted by psychedelic, announces that it has made a firm agreement with Stella. , a psychological intervention that focuses on treating PTSD, anxiety and depression through biological methods, for the sale of Five Clinics of Company Welfare by Utah (of “Agreement“) for 3.53 million dollars. The process is expected to close sooner or later November 30, 2024.
“This transaction marks an exciting new chapter in Numinus’ strategy to transform behavioral health care,” said Payton NyquvestFounder and CEO of Numinus. “Using our deep knowledge of patient care, where we have served nearly 50,000 unique individuals, over 200,000 individuals, and nearly 250,000 insured claims, we are now accelerating our mission by focusing through our partnership with Stella, we gain unprecedented access to operational data that will enable us to develop a SaaS solution that redefines how clinics work. from improving patient outcomes to improving efficiency and reimbursement processes.
As Cedar Clinical Research continues to lead the field in clinical trial research and our physician training programs provide world-class education, Numinus is positioned to support healthcare providers. global mental health. Together, we are building a future where innovative technology and compassionate care come together to transform mental health around the world.”
“As Stella continues to work at Numinus clinics, we are bringing more life-changing treatments. Utah community while at the same time supporting Numinus’ efforts to create new, innovative solutions that can change the future of how clinics are run,” he said. Michael GershenzonCo-Founder and CEO of Stella. “This partnership demonstrates our continued dedication to advocating for the advancement of behavioral health by creating best practices and practices that ultimately impact what matters most: better patient outcomes.” .”
“Stella will strengthen our clinical solutions as we leverage their deep clinical knowledge and patient care experience,” added Mr. Nyquvest. “With ketamine and Spravato™ emerging as important treatments for depression and related mental health conditions, we aim to ease the operational burdens that healthcare professionals face when are challenged to meet increasing maintenance requests. We expect strong demand for Numinus Network Solutions.”
Terms of Agreement
Stella MSO LLC will acquire five existing Numinus Wellness clinics Utah for general consideration of 3.53 million dollars:
General consideration 2.08 million dollars which is paid at the closing of the transaction
It is considered US$750,000 paid more than six equal monthly payments by 2025
Deferred compensation up to 0.7 million dollars will be paid in 2025
Stella will negotiate a partnership with Numinus, where Stella will provide continuous access to performance data from its network of 12 mental health clinics.
About Numinus
Numinus Wellness Inc. (TSX: NMI) helps people heal and live well by developing and delivering innovative mental health care and access to safe, evidence-based psychedelic-assisted therapy. The Numinus model – clinical support driven by technology, clinical trial research and comprehensive training of doctors – is at the forefront of change aimed at healing rather than managing the symptoms of depression, anxiety, trauma, pain and drug use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream medical practice and building the foundation for a healthy community.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook and Instagram.
About Stella:
Stella is an interventional psychotherapy dedicated to providing the most effective mental health protocols for acute trauma, stress, anxiety, depression and post-traumatic stress disorder. (PTSI). With a team of board-certified physicians, advanced psychiatrists, psychologists, psychiatrists, and advocates, Stella integrates biology, psychology, and psychiatry to address the complex needs of patients. . Stella Center has 20+ locations throughout United States and internationally Israel and Australia and treats more than 10,000 patients. Learn more at www.stellacenter.com and follow us on LinkedIn, TikTok, YouTube and Instagram.
Forward-looking statements
Statements and other information contained in this press release regarding future events constitute forward-looking statements. Forward-looking statements are often, but not always, characterized by the use of words such as “seek”, “expect”, “believe”, “plan”, “anticipate”, “anticipate” and “intend” and “may”, “will”, “must”, “could” or “could” or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements, including challenges and uncertainties regarding the parties’ ability to close the transaction. and cognitive ability. benefits, if any, from the business, and other risks mentioned in our annual information form November 29, 2023and is available on SEDAR at www.sedarplus.ca. Forward-looking statements are based on management’s estimates and opinions as of the date the statements are made. Numinus undertakes no obligation to update forward-looking statements even if conditions or management’s estimates or opinions may change without complying with applicable laws. Traders should not place undue reliance on forward-looking statements.
Cision
View original media download: https://www.prnewswire.com/news-releases/numinus-wellness-announces-sale-of-clinics-and-unique-data-partnership-to-increase-access-to- mental health care-302306737.html
List of Numinus Wellness Inc.
Cision
View original media download multimedia: http://www.newswire.ca/en/releases/archive/November2024/15/c1243.html
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
